Shelston IP Highly Recommended in IAM Patent 1000 2018

Intellectual Asset Management recently released their 2018 IAM Patent 1000 survey results. Shelston IP are proud to be listed as a Highly Recommended firm for prosecution.   We also congratulate Shelston IP attorneys Paul Harrison, Kieran Williams, Greg Whitehead, Grant Shoebridge and Chris Bevitt for being listed as standout attorney’s in their field. Keeping future enforcement priorities firmly in mind, Shelston IP

The role of IP in innovation

Innovation is generally understood as the process of bringing valuable new products (and services) to market, and has been highlighted as one of the key factors that determines the future success of an organisation.  Intellectual property (IP), and the management of the IP throughout the new product development process is a critical factor in successfully

Intellectual property – strategic use and management in the resources sector

A strong IP strategy is a vital part of any business, especially in the resources sector where innovation has historically provided key competitive advantages   Dr Michael Zammit, and Scott Philp, Shelston IP Senior Associates, provide insights into the strategic role of IP for entities operating in the resources sector. To read the full article,

Welcome to Shelston IP’s Australian Registered Designs Handbook.

The Australian registered designs system provides a fast and efficient mechanism for innovative companies to secure a monopoly for the visual appearance of commercially valuable products.  Arguably, the Australian registered designs system is somewhat underutilised by those companies who would most benefit from its features.   To assist innovative companies in gaining a better understanding

ARENA funding for Australian Cleantech start-ups: How patents can assist

Australian start-ups are often cash-poor – and IP costs money.  We get that.  To that end, Shelston IP’s “Cleantech” team is constantly on the lookout for ways in which our local start-up community can combine the “necessary evil” of expenditure on intangible assets with funding sources specifically dedicated to such purposes.  With ARENA, we may

A clear mistake in a claim term cannot be corrected through claim construction

In GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited [2018] FCAFC 71, the Full Federal Court has found that terms used in claims cannot be interpreted beyond their plain meaning.  Such a decision emphasises that great care is required when drafting claims that contain words or phrases that have a

Page 1 of 4412345...102030...Last »